The majority of patients with insulin-treated diabetes inject themselves around four times a day. They monitor their blood glucose via a finger prick. They have to adjust the insulin dose to their meals and exercise activities. Still, episodes of low blood glucose occur, which can lead to hospitalisation and complications.

PCDIAB brings together three small to medium-sized enterprises, three academic institutions and one industrial partner. It combines expertise on algorithms, microelectronics, system integration, wireless communication, remote alarms, diabetes, glucose metabolism and risk management to create new artificial pancreas systems.